Global Medical Affairs Director, Open to flexibility
Global Medical Affairs Director, Open to flexibility
- Works in partnership with country teams to create and then implement global medical affairs strategies.
- Seeks opportunities to bring in external and internal insights to shape strategy
- Works together with commercial, R&D, and other key stakeholders to shape the life-cycle management plan for Anti GM-CSF
- Turns current and emerging evidence into content of value to both internal and external audiences
Supporting the anti GM-CSF Global MA team and the global medical affairs leader (GMAL) with the following activities:
- Engages with senior stakeholders in assigned LOCs to facilitate launches and ongoing support of Anti GM-CSF, including reviewing and optimising medical affairs tactical plans and sharing learning/ best practice.
- Ensures country medical affairs colleagues have a robust knowledge of the relevant and emerging clinical evidence, supporting their continuous training by creating high quality scientific engagement materials for both internal and external use as well as directly supporting when needed
- Partners with Marketing, Market Access and core country teams to generate content of high scientific quality for promotional use including at international congresses
- Develops and manages publications plan.
- Partners with other above-country and country colleagues to bring in medical insights from across assigned LOCs and integrates/ prioritises these to inform global medical affairs plans.
- Works with R&D, VEO, other disciplines, and country teams to identify evidence generation needs and plans to address them. Areas include: RA, other indications, mechanistic, value evidence, real world outcomes, and many others.
- Input into and delivery of life cycle management plans, including phase 3b/4 plans.
- Develop internal and external communication content on a vast array of disease-specific and Anti GM-CSF specific topics to address internal and external needs. Can work with traditional and novel channels of communication.
Closing date for applications will be Friday 16th November 2018.
- PhD with experience in immunology/rheumatology
- Broad drug development expertise with robust knowledge of regulatory / market access and reimbursement requirements.
- Considerable experience in Medical Affairs in relevant therapeutic area(s), including launch/ peri-launch support requirements.
- Robust understanding of internal (where applicable) and external promotional codes of practice and regulations.
- Demonstrated ability to assess evidence generation needs
- Track record of building strong internal and external networks.
- Demonstrated ability to manage complexity and cultural diversity.
- Previous cross-portfolio and above-country experience preferred.
- Strong English communication skills both verbal and written a must
- Physician with specialist qualification in immunology/rheumatology
- ABPI certification
GSK is a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. We have a significant global presence with commercial operations in more than 150 countries, a network of 89 manufacturing sites, and large R&D centres in the UK, USA, Belgium and China.
At GSK we are leaders in what we do - our pharmaceuticals business is made up of innovative and established medicines and holds leading positions in respiratory disease and HIV, in 2015 we distributed more than 690 million doses of vaccines to over 150 countries, and our Consumer Healthcare group has a portfolio of some of the world's most trusted and bestselling brands. As a company our mission is to help people do more, feel better, live longer.
Within our R&D function, our Medical Franchise model provides a lean organisation with faster, higher-quality, decision making. This results in enhanced access for patients to new products via successful and sustainable launches across multiple Local Operating Companies (LOCs).
Rheumatoid arthritis is a chronic, systemic inflammatory condition characterised by pain, joint swelling, stiffness, joint destruction and disability. It affects 24.5 million people globally1. Despite the use of disease modifying antirheumatic drugs, regarded the cornerstone of treatment, of which methotrexate is the gold standard, a substantial proportion of patients either fail to respond or have inadequate response. There is therefore a need for more effective treatments with alternative mechanism of action.
About the asset
GSK3196165 is a human monoclonal antibody that inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF), a type of protein that plays a central role in a broad range of immune mediated diseases, including rheumatoid arthritis. It activates cells, including macrophages (a white blood cell which plays a key role in the inflammatory process), leading to inflammation and joint damage. GSK3196165 neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor.
You may apply for this position online by selecting the Apply now button.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorisation before referring any candidates to GSK. The obtaining of prior written authorisation is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorisation being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.